Safety of PD-1 Inhibitors in Squamous Non-Small Cell Lung Cancer
2 Mga view
• 07/14/23
0
0
I-embed
administrator
Mga subscriber
The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, identify patients with squamous non-small cell lung cancer who may benefit from immune checkpoint inhibitors and the management of any related toxicity.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento